Clinical Trials Browser

Phase 2 × volociximab × Dermatologic × Clear all

NCT00369395 2012-04-27

A Study of Volociximab in Metastatic Melanoma

Phase 2 Terminated

Melanoma

NCT00099970 2008-08-05

Volociximab in Combination With DTIC in Patients With Metastatic Melanoma Not Previously Treated With Chemotherapy

Phase 2 Completed

Melanoma, Neoplasm Metastasis